Lynn Seely has an estimated net worth of $35.6 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Blueprint Medicines Corp, Lyell Immunopharma, Inc., and MEDIVATION, INC..

2014 was Lynn Seely's most active year for acquiring shares with 24 total transactions. Lynn Seely's most active month to acquire stocks was the month of May. 2014 was Lynn Seely's most active year for disposing of shares, totalling 52 transactions. Lynn Seely's most active month to dispose stocks was the month of June. 2012 saw Lynn Seely paying a total of $3,597,675.00 for 262,500 shares, this is the most they've acquired in one year. In 2012 Lynn Seely cashed out on 384,955 shares for a total of $17,431,187.10, their largest year based on trade value.